2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW)
Combined formulation of Doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGA-encapsulated nanocarrier improves anti-tumor activity
DOI Bookmark: 10.1109/BIBMW.2012.6470261
Authors
Stanley Moffatt, School of Informatics, Health and Allied Sciences, Regent University College of Science and Technology, Accra, GhanaRichard Cristiano, Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Rose Boyle, Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU67RX, United Kingdom